The FDA has approved the Vanquish Water Vapor Ablation System, which uses steam to destroy prostate tumors. However, the ...
In a recent interview with CURE, Dr. Kai Tsao broke down current treatment advancements for patients with prostate cancer.
Artera, a developer of multimodal AI-based prognostic and predictive cancer tests, today announced the commercial launch of ...
Doctors at the Urology Group are pioneering the use of artificial intelligence to enhance prostate cancer treatment, offering ...
The therapy - which involves a robotic-assisted, high-pressure water jet - is less invasive than traditional surgery.
A groundbreaking trial for a prostate cancer treatment with fewer side effects has launched in the UK. Backed by the ...
The treatment is suitable for men whose cancer has not spread outside of the prostate gland or has spread to the area just ...
Capital Brief on MSN
Telix doses first patient under prostate cancer therapy study
Telix Pharmaceuticals has dosed its first patient for the second part of a global study to evaluate the lead prostate cancer ...
Targeted prostate cancer screening is helping identify men with early cases of the disease, says a group of Norwich health ...
PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA ...
FDA approval marks Alpha Tau’s fifth simultaneous active U.S. IDE as the Company expands Alpha DaRT’s reach into recurrent ...
1don MSN
Telix Pharmaceuticals updates investors as first patient is dosed in Phase 3 prostate cancer trial
Telix Pharmaceuticals share price in focus after dosing the first patient in Part 2 of its Phase 3 prostate cancer trial and confirming global expansion plans.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback